logo
A new indication for statins to prevent venous thromboembolism? Not yet
HMG-CoA reductase inhibitors, other lipid-lowering medication, antiplatelet therapy, and the risk of venous thrombosis
Arterial cardiovascular events, statins, low-dose aspirin and subsequent risk of venous thromboembolism
Cardiac involvement in acute thrombotic thrombocytopenic purpura
Atherosclerosis in thrombotic primary antiphospholipid syndrome
Cancer begets venous thromboembolism, but is venous thromboembolism a risk factor for cancer?
The long-term risk of cancer in patients with a first episode of venous thromboembolism
Study of bioaccumulation of dalteparin at a prophylactic dose in patients with various degrees of impaired renal function
The pharmacokinetics of idraparinux, a long-acting indirect factor Xa inhibitor
AVE5026, a new hemisynthetic ultra-low-molecular-weight heparin for the prevention of venous thromboembolism in patients after total knee replacement surgery - TREK
The association of depression with platelet activation
Inflammation in deep vein thrombosis and the development of post-thrombotic syndrome
Lipid biomarkers, hormone therapy and the risk of venous thromboembolism in women
Incidence, risk profile and morphological pattern of venous thromboembolism after prostate cancer surgery
Does an active sun exposure habit lower the risk of venous thrombotic events? A D-lightful hypothesis
Elevated D-dimer levels predict recurrence in patients with idiopathic venous thromboembolism
Chemotherapeutic agents doxorubicin and epirubicin induce a procoagulant phenotype on endothelial cells and blood monocytes
Molecular mechanism of the interaction between activated factor XIII and its glutamine donor peptide substrate
Racial differences in endotoxin-induced tissue factor-triggered coagulation
Genetic alteration of the D2 domain abolishes von Willebrand factor multimerization and trafficking into storage
rFVIIa and a new enhanced rFVIIa-analogue, NN1731, reduce bleeding in clopidogrel-treated and in thrombocytopenic rats
Non-classical anti-factor VIII C2 domain antibodies are pathogenic in a murine in vivo bleeding model
Functional analysis of mutant variants of thrombin-activatable fibrinolysis inhibitor resistant to activation by thrombin or plasmin
How useful is light transmission platelet aggregometry for the diagnosis of bleeding disorders?
Diagnostic utility of light transmission platelet aggregometry
Platelet adhesion to multimerin 1 in vitro
Rap1b is critical for glycoprotein VI-mediated but not ADP receptor-mediated α2β1 activation
p38 mitogen-activated protein kinase targets the production of proinflammatory endothelial microparticles
Autoantibodies to heat shock protein 60 promote thrombus formation in a murine model of arterial thrombosis
Hemophilia severity score system
JAK2V617F mutation in patients with arterial thrombosis in the absence of overt myeloproliferative disease
An alternative diagnostic strategy in young women with suspected pulmonary embolism
Underweight is associated with a reduced risk of venous thromboembolism. Results from the EDITH case-control study
Join ISTH